46 reports of this reaction
2.5% of all CEFPODOXIME PROXETIL reports
#4 most reported adverse reaction
DYSPNOEA is the #4 most commonly reported adverse reaction for CEFPODOXIME PROXETIL, manufactured by Amici Pharmaceuticals, LLC.. There are 46 FDA adverse event reports linking CEFPODOXIME PROXETIL to DYSPNOEA. This represents approximately 2.5% of all 1,861 adverse event reports for this drug.
Patients taking CEFPODOXIME PROXETIL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is a less commonly reported adverse event for CEFPODOXIME PROXETIL, but still significant enough to appear in the safety profile.
In addition to dyspnoea, the following adverse reactions have been reported for CEFPODOXIME PROXETIL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 46 FDA reports for CEFPODOXIME PROXETIL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 2.5% of all adverse event reports for CEFPODOXIME PROXETIL, making it a notable side effect.
If you experience dyspnoea while taking CEFPODOXIME PROXETIL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.